Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Pharming Group (PHGUF) Starts Presentation at 25th Annual ROTH Conference

Posted on March 19, 2013 by Mission IR

Pharming Group is a biotechnology company that develops products for the treatment of unmet medical needs, including RUCONEST® for the treatment of angioedema attacks in patients with HAE. The company operates through two business segments: Recombinant proteins and DNage. PHGUF focuses on the development, production and commercialization of human therapeutic proteins to be used as innovative therapies. For more information, visit the company’s Web site: http://www.pharming.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *